B. Kearney

437 total citations
10 papers, 308 citations indexed

About

B. Kearney is a scholar working on Surgery, Transplantation and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, B. Kearney has authored 10 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Transplantation and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in B. Kearney's work include Transplantation: Methods and Outcomes (9 papers), Renal Transplantation Outcomes and Treatments (8 papers) and Viral Infections and Immunology Research (3 papers). B. Kearney is often cited by papers focused on Transplantation: Methods and Outcomes (9 papers), Renal Transplantation Outcomes and Treatments (8 papers) and Viral Infections and Immunology Research (3 papers). B. Kearney collaborates with scholars based in United States. B. Kearney's co-authors include L. Czer, Carlos Blanche, Andreas Kamlot, Alfredo Trento, D. Chang, Joshua Chung, J. Patel, M. Kittleson, F. Esmailian and Danny Ramzy and has published in prestigious journals such as Journal of Thoracic and Cardiovascular Surgery and The Journal of Heart and Lung Transplantation.

In The Last Decade

B. Kearney

10 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Kearney United States 4 300 156 154 49 7 10 308
M. Sabatino Italy 7 134 0.4× 96 0.6× 32 0.2× 45 0.9× 7 1.0× 16 162
C. Soto Australia 3 128 0.4× 75 0.5× 32 0.2× 12 0.2× 6 0.9× 10 158
Barbara Wilkey United States 9 120 0.4× 72 0.5× 15 0.1× 21 0.4× 28 4.0× 16 142
A. Velleca United States 6 122 0.4× 83 0.5× 27 0.2× 66 1.3× 9 1.3× 27 192
Jan Van Slambrouck Belgium 7 96 0.3× 30 0.2× 35 0.2× 10 0.2× 36 5.1× 29 123
Karol Mudy United States 6 105 0.3× 67 0.4× 22 0.1× 60 1.2× 26 3.7× 15 169
Vicens Brossa-Loidi Spain 5 113 0.4× 92 0.6× 12 0.1× 30 0.6× 3 0.4× 7 132
Alessandra Verzelloni Sef United Kingdom 6 51 0.2× 33 0.2× 9 0.1× 8 0.2× 3 0.4× 12 57
Alex Kantor United States 4 60 0.2× 24 0.2× 21 0.1× 111 2.3× 15 2.1× 5 150
Eyal Nachum Israel 4 42 0.1× 14 0.1× 8 0.1× 48 1.0× 31 4.4× 18 84

Countries citing papers authored by B. Kearney

Since Specialization
Citations

This map shows the geographic impact of B. Kearney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Kearney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Kearney more than expected).

Fields of papers citing papers by B. Kearney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Kearney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Kearney. The network helps show where B. Kearney may publish in the future.

Co-authorship network of co-authors of B. Kearney

This figure shows the co-authorship network connecting the top 25 collaborators of B. Kearney. A scholar is included among the top collaborators of B. Kearney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Kearney. B. Kearney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Czer, L., M. Kittleson, J. Patel, et al.. (2019). 10-Year Outcomes in Heart-Kidney Transplant Patients: Is There a Protective Effect for the Donor Heart?. The Journal of Heart and Lung Transplantation. 38(4). S217–S217. 1 indexed citations
2.
Velleca, A., B. Kearney, J. Patel, et al.. (2019). Intravenous Methamphetamine Does Not Appear to Be a Contraindication for Heart Donation in Heart Transplantation. The Journal of Heart and Lung Transplantation. 38(4). S92–S92. 1 indexed citations
3.
Kittleson, M., Lillian Benck, J. Patel, et al.. (2018). Predicted heart mass is the optimal metric for size match in heart transplantation. The Journal of Heart and Lung Transplantation. 38(2). 156–165. 141 indexed citations
4.
Patel, Jayesh, Mark D. Kittleson, Joseph Kwan, et al.. (2017). Donor Heart Turn Down in the Field: What’s Going On?. The Journal of Heart and Lung Transplantation. 36(4). S44–S44. 1 indexed citations
5.
Kittleson, M., L. Czer, A. Velleca, et al.. (2016). Proliferation Signal Inhibitors Prevent Donor-Specific Antibody Production in Sensitized Patients after Heart Transplantation. The Journal of Heart and Lung Transplantation. 35(4). S281–S281. 1 indexed citations
6.
Patel, J., M. Kittleson, L. Czer, et al.. (2016). Does ACE Inhibitor Use in Heart Transplantation Decrease the Development of Cardiac Allograft Vasculopathy?. The Journal of Heart and Lung Transplantation. 35(4). S198–S198. 1 indexed citations
7.
Patel, J., M. Kittleson, L. Czer, et al.. (2016). Severity of Hypertension After Heart Transplant: Does It Impact Outcome?. The Journal of Heart and Lung Transplantation. 35(4). S295–S295. 1 indexed citations
8.
Blanche, Carlos, Andreas Kamlot, B. Kearney, et al.. (2002). Heart transplantation with donors fifty years of age and older. Journal of Thoracic and Cardiovascular Surgery. 123(4). 810–815. 61 indexed citations
9.
Blanche, Carlos, et al.. (2001). Combined heart-kidney transplantation with single-donor allografts. Journal of Thoracic and Cardiovascular Surgery. 122(3). 495–500. 35 indexed citations
10.
Blanche, Carlos, B. Kearney, Meenu Sandhu, et al.. (2001). Heart transplantation in patients seventy years of age and older: A comparative analysis of outcome. Journal of Thoracic and Cardiovascular Surgery. 121(3). 532–541. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026